{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:15:41Z","timestamp":1788984941306,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007494","name":"Fondation Plan Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jclinepi.2026.112417","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:41:59Z","timestamp":1783665719000},"page":"112417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The DECISION study: protocol for the development and internal validation of a multimodal decision-making capacity framework"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-6240","authenticated-orcid":false,"given":"Carolin I.","family":"Kurz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Tegethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Gelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Gkempelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortese","family":"Neziraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Schuhbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Rahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-4426","authenticated-orcid":false,"given":"Myriam","family":"Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie F.","family":"Keidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jclinepi.2026.112417_bib1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1176\/ps.48.11.1415","article-title":"The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions","volume":"48","author":"Grisso","year":"1997","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000109763","article-title":"Measuring decision-making capacity in cognitively impaired individuals","volume":"16","author":"Karlawish","year":"2008","journal-title":"Neurosignals"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12910-020-00498-y","article-title":"Evaluation of decision-making capacity in patients with dementia: challenges and recommendations from a secondary analysis of qualitative interviews","volume":"21","author":"Poppe","year":"2020","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.jclinepi.2026.112417_bib4","series-title":"Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals","author":"Grisso","year":"1998"},{"key":"10.1016\/j.jclinepi.2026.112417_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.1024967","article-title":"Healthcare decision-making capacity in old age: a qualitative study","volume":"13","author":"Amaral","year":"2022","journal-title":"Front Psychol"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112417_bib6","first-page":"413","article-title":"[MacCAT-T between Claim and Practice - Challenges of Assessing Capacity for Consent in Dementia]","volume":"92","author":"Rolfes","year":"2024","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.jclinepi.2026.112417_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad171","article-title":"Decision-making capacity in older medical in-patients: frequency of assessment and rates of incapacity by decision-type and underlying brain\/mind impairment","volume":"52","author":"Gan","year":"2023","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112417_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1017\/S1041610220004056","article-title":"Decisional capacity to consent to treatment and research in patients affected by Mild Cognitive Impairment. A systematic review and meta-analysis","volume":"34","author":"Parmigiani","year":"2022","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112417_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3233\/JAD-180311","article-title":"Medical and research consent decision-making capacity in patients with Alzheimer's Disease: a systematic review","volume":"65","author":"van Duinkerken","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112417_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/1516-4446-2021-2180","article-title":"Patterns of impairment in decision-making capacity in Alzheimer's disease and its relationship with cognitive and clinical variables","volume":"44","author":"Santos","year":"2022","journal-title":"Braz J Psychiatry"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112417_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","article-title":"Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers","volume":"20","author":"Thal","year":"2025","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/ADR-230049","article-title":"More similar than different: memory, executive functions, cortical thickness, and glucose metabolism in biomarker-positive Alzheimer's Disease and behavioral variant frontotemporal dementia","volume":"8","author":"Keith","year":"2024","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.jclinepi.2026.112417_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112417_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma Abeta42\/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112417_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta((1-42\/1-40)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112417_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/HRP.0000000000000163","article-title":"Dementia, decision making, and capacity","volume":"25","author":"Darby","year":"2017","journal-title":"Harv Rev Psychiatry"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112417_bib21","doi-asserted-by":"crossref","first-page":"fcae396","DOI":"10.1093\/braincomms\/fcae396","article-title":"Glial fibrillary acidic protein in Alzheimer's disease: a narrative review","volume":"6","author":"Leipp","year":"2024","journal-title":"Brain Commun"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112417_bib22","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jclinepi.2026.112417_bib23","author":"Europe"},{"key":"10.1016\/j.jclinepi.2026.112417_bib24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMcp074045","article-title":"Clinical practice. Assessment of patients' competence to consent to treatment","volume":"357","author":"Appelbaum","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2026.112417_bib25","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jclinepi.2026.112417_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.26465","article-title":"Microglial activation and connectivity in alzheimer disease and aging","volume":"92","author":"Rauchmann","year":"2022","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112417_bib27","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00406-025-02013-z","article-title":"Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer\u2019s disease and corticobasal syndrome","volume":"275","author":"Kurz","year":"2025","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.jclinepi.2026.112417_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jclinepi.2026.112417_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making Test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Perceptual Mot Skills"},{"key":"10.1016\/j.jclinepi.2026.112417_bib30","series-title":"Klaus; Weniger, Doris; Willmes, Klaus, Aachener Aphasie Test (AAT)","author":"Huber","year":"1983"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112417_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/bdm.414","article-title":"A domain-specific risk-attitude scale: measuring risk perceptions and risk behaviors","volume":"15","author":"Weber","year":"2002","journal-title":"J Behav Decis Making"},{"key":"10.1016\/j.jclinepi.2026.112417_bib32","series-title":"Neuropsychological Rehabilitation After Brain Injury","author":"Prigatano","year":"1986"},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112417_bib33","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/00140139508925202","article-title":"Cognitive failures and performance differences: validation studies of a German version of the cognitive failures questionnaire","volume":"38","author":"Klumb","year":"1995","journal-title":"Ergonomics"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112417_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-132027","article-title":"The subjective cognitive decline questionnaire (SCD-Q): a validation study","volume":"41","author":"Rami","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"39","key":"10.1016\/j.jclinepi.2026.112417_bib35","doi-asserted-by":"crossref","first-page":"31056","DOI":"10.1007\/s12144-024-06668-0","article-title":"Development of a short version of the German subjective cognitive decline questionnaire (SCD-Q17): a principal component analysis approach to item reduction","volume":"43","author":"Tegethoff","year":"2024","journal-title":"Curr Psychol"},{"issue":"7","key":"10.1016\/j.jclinepi.2026.112417_bib36","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1038\/s41380-025-03021-0","article-title":"Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer s disease","volume":"30","author":"Mengel","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-023-01341-3","article-title":"Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study","volume":"15","author":"Perna","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jclinepi.2026.112417_bib38","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","article-title":"Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures","volume":"27","author":"Palmqvist","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jclinepi.2026.112417_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3758\/s13415-011-0083-5","article-title":"Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions","volume":"12","author":"Niendam","year":"2012","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jclinepi.2026.112417_bib41","article-title":"The relationship between retinal nerve fiber layer thickness and clinical symptoms of Alzheimer's Disease","volume":"12","author":"Lian","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1016\/j.jclinepi.2026.112417_bib42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2024.04.014","article-title":"Signature of altered retinal microstructures and electrophysiology in schizophrenia spectrum disorders is associated with disease severity and polygenic risk","volume":"96","author":"Boudriot","year":"2024","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.jclinepi.2026.112417_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-022-00998-6","article-title":"The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals","volume":"14","author":"Lopez-de-Eguileta","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jclinepi.2026.112417_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1101950","article-title":"A cross-sectional study of retinal vessel changes based on optical coherence tomography angiography in Alzheimer's disease and mild cognitive impairment","volume":"15","author":"Ma","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"10.1016\/j.jclinepi.2026.112417_bib45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/alz.12433","article-title":"Diversity in Alzheimer's disease drug trials: the importance of eligibility criteria","volume":"18","author":"Franzen","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jclinepi.2026.112417_bib46","doi-asserted-by":"crossref","first-page":"e0124500","DOI":"10.1371\/journal.pone.0124500","article-title":"Systematic review: representativeness of participants in RCTs of acetylcholinesterase inhibitors","volume":"10","author":"Leinonen","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:48:34Z","timestamp":1788983314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0895435626002933"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112417","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The DECISION study: protocol for the development and internal validation of a multimodal decision-making capacity framework","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112417"}}